Selvarangan Ponnazhagan

University of Alabama at Birmingham — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index6.4kcitations267works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(66), Bone Metabolism and Diseases(49), Bone health and treatments(39), Immune cells in cancer(31), RNA Interference and Gene Delivery(25)

Publications267 total

Abstract C051: Genomic and spatial immune biomarkers predictive of chemoimmunotherapy response in triple-negative breast cancer
Cancer Immunology Research·2026
The role of osteomimicry factors in prostate cancer progression and metastasis
American Journal of Physiology-Cell Physiology·2026
Patient-Derived Three-Dimensional Lung Tumor Models to Evaluate Response to Immunotherapy
2025Open Access
Abstracts of the 2nd International Electronic Conference on Genes
2025Open Access
P2.11A.02 Proteomics-Based Target Identification for Optimizing Bispecific Antibody Use in NSCLC
Journal of Thoracic Oncology·2024Open Access
Editorial: Implications of immune landscape in tumor microenvironment
Frontiers in Immunology·2024· 1 citedOpen Access
Encapsulation of AAVs into protein vault nanoparticles as a novel solution to gene therapy’s neutralizing antibody problem
2023· 2 citedOpen Access
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology·2023· 2 cited
Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
2023Open Access
Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
2023Open Access
Supplementary Figure from Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival
2023Open Access
Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
2023Open Access
Data from Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival
2023Open Access
Supplementary Methods from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
2023Open Access
Data from Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival
2023Open Access
Supplementary Figure from Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival
2023Open Access
Supplementary Methods from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
2023Open Access
Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
2023Open Access
Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
2023Open Access
Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Arun Srivastava(15), Sanjay Kumar(10), Diptiman Chanda(6), Anandi Sawant(6), Jessy S. Deshane(6), Xu-Shan Wang(6), Mervin C. Yöder(6), Keyun Qing(6), Dagmar Marie Kube(6), Jonathan A. Hensel(4), Gene P. Siegal(4), Gandham Mahendra(4), Changchun Ren(3), Shang Zhen Zhou(3), Pinku Mukherjee(3), Benjawan Khuntirat(3), Cathryn Mah(3), Cara C. Schafer(3), Kenneth P. Hough(3), Xiaolin Wang(3)